We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
Read MoreHide Full Article
In the latest trading session, Veeva Systems (VEEV - Free Report) closed at $301.63, marking a +1.95% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.02%. Meanwhile, the Dow lost 0.35%, and the Nasdaq, a tech-heavy index, lost 0.15%.
Shares of the provider of cloud-based software services for the life sciences industry have appreciated by 11.36% over the course of the past month, outperforming the Medical sector's gain of 1.06%, and the S&P 500's gain of 2.05%.
Investors will be eagerly watching for the performance of Veeva Systems in its upcoming earnings disclosure. The company is predicted to post an EPS of $2.33, indicating a 14.22% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $933.79 million, up 15.11% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $9.22 per share and revenue of $3.69 billion, which would represent changes of +13.83% and +15.35%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. As of now, Veeva Systems holds a Zacks Rank of #3 (Hold).
With respect to valuation, Veeva Systems is currently being traded at a Forward P/E ratio of 32.09. For comparison, its industry has an average Forward P/E of 32.09, which means Veeva Systems is trading at no noticeable deviation to the group.
Investors should also note that VEEV has a PEG ratio of 0.92 right now. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The average PEG ratio for the Medical Info Systems industry stood at 3.17 at the close of the market yesterday.
The Medical Info Systems industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 83, positioning it in the top 34% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, Veeva Systems (VEEV - Free Report) closed at $301.63, marking a +1.95% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.02%. Meanwhile, the Dow lost 0.35%, and the Nasdaq, a tech-heavy index, lost 0.15%.
Shares of the provider of cloud-based software services for the life sciences industry have appreciated by 11.36% over the course of the past month, outperforming the Medical sector's gain of 1.06%, and the S&P 500's gain of 2.05%.
Investors will be eagerly watching for the performance of Veeva Systems in its upcoming earnings disclosure. The company is predicted to post an EPS of $2.33, indicating a 14.22% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $933.79 million, up 15.11% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $9.22 per share and revenue of $3.69 billion, which would represent changes of +13.83% and +15.35%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. As of now, Veeva Systems holds a Zacks Rank of #3 (Hold).
With respect to valuation, Veeva Systems is currently being traded at a Forward P/E ratio of 32.09. For comparison, its industry has an average Forward P/E of 32.09, which means Veeva Systems is trading at no noticeable deviation to the group.
Investors should also note that VEEV has a PEG ratio of 0.92 right now. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The average PEG ratio for the Medical Info Systems industry stood at 3.17 at the close of the market yesterday.
The Medical Info Systems industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 83, positioning it in the top 34% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.